Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 20 Aug 2026

MedPlus Health Services is reducing aggressive in-store promotion of its private-label prescription medicines after store employees encouraged customers to switch from doctor-prescribed brands to cheaper MedPlus-branded alternatives.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

MedPlus Health Services is reducing aggressive in-store promotion of its private-label prescription medicines after store employees encouraged customers to switch from doctor-prescribed brands to cheaper MedPlus-branded alternatives.

moneycontrol.com19 Aug 2026

MedPlus Health Services has eased its aggressive in-store promotion of private-label prescription medicines after some store employees pushed substitutions too aggressively, with CEO Madhukar Gangadi stating employees have been asked to suggest alternatives and leave the final decision to customers.

moneycontrol.com19 Aug 2026

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.